HEADER CELL INVASION 21-AUG-17 5OTF TITLE MRCK BETA IN COMPLEX WITH BDP-00009066 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE MRCK BETA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CDC42-BINDING PROTEIN KINASE BETA,CDC42BP-BETA,DMPK-LIKE COMPND 5 BETA,MYOTONIC DYSTROPHY KINASE-RELATED CDC42-BINDING KINASE BETA, COMPND 6 MYOTONIC DYSTROPHY PROTEIN KINASE-LIKE BETA; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CDC42BPB, KIAA1124; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS MYOTONIC DYSTROPHY KINASE-RELATED CDC42-BINDING KINASE, METASTASIS, KEYWDS 2 CELL INVASION, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.W.SCHUETTELKOPF REVDAT 3 17-JAN-24 5OTF 1 REMARK REVDAT 2 25-APR-18 5OTF 1 JRNL REVDAT 1 21-FEB-18 5OTF 0 JRNL AUTH M.UNBEKANDT,S.BELSHAW,J.BOWER,M.CLARKE,J.CORDES,D.CRIGHTON, JRNL AUTH 2 D.R.CROFT,M.J.DRYSDALE,M.J.GARNETT,K.GILL,C.GRAY, JRNL AUTH 3 D.A.GREENHALGH,J.A.M.HALL,J.KONCZAL,S.LILLA,D.MCARTHUR, JRNL AUTH 4 P.MCCONNELL,L.MCDONALD,L.MCGARRY,H.MCKINNON,C.MCMENEMY, JRNL AUTH 5 M.MEZNA,N.A.MORRICE,J.MUNRO,G.NAYLOR,N.RATH, JRNL AUTH 6 A.W.SCHUTTELKOPF,M.SIME,M.F.OLSON JRNL TITL DISCOVERY OF POTENT AND SELECTIVE MRCK INHIBITORS WITH JRNL TITL 2 THERAPEUTIC EFFECT ON SKIN CANCER. JRNL REF CANCER RES. V. 78 2096 2018 JRNL REFN ESSN 1538-7445 JRNL PMID 29382705 JRNL DOI 10.1158/0008-5472.CAN-17-2870 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0135 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.77 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 28326 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1431 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1961 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.89 REMARK 3 BIN R VALUE (WORKING SET) : 0.2860 REMARK 3 BIN FREE R VALUE SET COUNT : 102 REMARK 3 BIN FREE R VALUE : 0.3760 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3308 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 156 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.07 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.01000 REMARK 3 B22 (A**2) : -1.62000 REMARK 3 B33 (A**2) : 1.16000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.36000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.199 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.162 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.151 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.654 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.954 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.943 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3378 ; 0.019 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3142 ; 0.000 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4573 ; 1.801 ; 1.965 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7228 ; 3.752 ; 3.005 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 409 ; 4.315 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 160 ;33.352 ;24.062 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 564 ;15.717 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 19 ;19.443 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 493 ; 0.140 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3804 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 786 ; 0.010 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1642 ; 1.620 ; 1.921 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1641 ; 1.620 ; 1.922 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2049 ; 2.596 ; 2.869 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 4 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A -1 A 417 REMARK 3 RESIDUE RANGE : L 1 L 9999 REMARK 3 RESIDUE RANGE : W 1 W 9999 REMARK 3 RESIDUE RANGE : X 1 X 9999 REMARK 3 ORIGIN FOR THE GROUP (A): 18.7090 1.0990 19.0120 REMARK 3 T TENSOR REMARK 3 T11: 0.1251 T22: 0.2258 REMARK 3 T33: 0.1053 T12: -0.0270 REMARK 3 T13: -0.1113 T23: 0.0022 REMARK 3 L TENSOR REMARK 3 L11: 2.0157 L22: 0.4454 REMARK 3 L33: 1.3855 L12: -0.4830 REMARK 3 L13: 1.1039 L23: -0.3252 REMARK 3 S TENSOR REMARK 3 S11: -0.0264 S12: -0.1644 S13: 0.0192 REMARK 3 S21: 0.1036 S22: 0.0359 S23: -0.0800 REMARK 3 S31: -0.0679 S32: 0.1701 S33: -0.0095 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: U VALUES : WITH TLS ADDED HYDROGENS REMARK 3 HAVE BEEN ADDED IN THE RIDING POSITIONS REMARK 4 REMARK 4 5OTF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-AUG-17. REMARK 100 THE DEPOSITION ID IS D_1200005649. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-DEC-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.88 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS 2014-01-10 REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.3.11 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29757 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 29.770 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.08500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.85600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 4UAK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12-18% PEG 3350, 100MM AMMONIUM REMARK 280 SULPHATE, 100MM SODIUM POTASSIUM TARTRATE, 100MM BIS-TRIS PH 5.6, REMARK 280 VAPOR DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 57.59500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 22.02800 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 57.59500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 22.02800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6790 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 35840 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -56.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 CL CL A 501 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 706 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 756 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 373 REMARK 465 ASP A 374 REMARK 465 ASP A 375 REMARK 465 VAL A 376 REMARK 465 LEU A 377 REMARK 465 ARG A 378 REMARK 465 ASN A 379 REMARK 465 THR A 380 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 9 CG CD CE NZ REMARK 480 LYS A 114 CG CD CE NZ REMARK 480 ASP A 227 CG OD1 OD2 REMARK 480 GLN A 232 CG CD OE1 NE2 REMARK 480 SER A 234 OG REMARK 480 LYS A 257 CE NZ REMARK 480 GLU A 284 CG CD OE1 OE2 REMARK 480 LYS A 292 CG CD CE NZ REMARK 480 GLU A 297 CG CD OE1 OE2 REMARK 480 GLN A 301 CD OE1 NE2 REMARK 480 ARG A 326 CG CD NE CZ NH1 NH2 REMARK 480 GLU A 381 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 169 15.58 81.14 REMARK 500 ASP A 170 6.36 85.75 REMARK 500 HIS A 195 33.38 73.94 REMARK 500 ASP A 200 45.02 -150.05 REMARK 500 ASP A 218 77.62 56.15 REMARK 500 ASP A 253 -166.83 -103.96 REMARK 500 ASN A 295 44.38 -103.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue AQ5 A 504 DBREF 5OTF A 2 417 UNP Q9Y5S2 MRCKB_HUMAN 2 417 SEQADV 5OTF GLY A -1 UNP Q9Y5S2 EXPRESSION TAG SEQADV 5OTF GLY A 0 UNP Q9Y5S2 EXPRESSION TAG SEQADV 5OTF SER A 1 UNP Q9Y5S2 EXPRESSION TAG SEQRES 1 A 419 GLY GLY SER SER ALA LYS VAL ARG LEU LYS LYS LEU GLU SEQRES 2 A 419 GLN LEU LEU LEU ASP GLY PRO TRP ARG ASN GLU SER ALA SEQRES 3 A 419 LEU SER VAL GLU THR LEU LEU ASP VAL LEU VAL CYS LEU SEQRES 4 A 419 TYR THR GLU CYS SER HIS SER ALA LEU ARG ARG ASP LYS SEQRES 5 A 419 TYR VAL ALA GLU PHE LEU GLU TRP ALA LYS PRO PHE THR SEQRES 6 A 419 GLN LEU VAL LYS GLU MET GLN LEU HIS ARG GLU ASP PHE SEQRES 7 A 419 GLU ILE ILE LYS VAL ILE GLY ARG GLY ALA PHE GLY GLU SEQRES 8 A 419 VAL ALA VAL VAL LYS MET LYS ASN THR GLU ARG ILE TYR SEQRES 9 A 419 ALA MET LYS ILE LEU ASN LYS TRP GLU MET LEU LYS ARG SEQRES 10 A 419 ALA GLU THR ALA CYS PHE ARG GLU GLU ARG ASP VAL LEU SEQRES 11 A 419 VAL ASN GLY ASP CYS GLN TRP ILE THR ALA LEU HIS TYR SEQRES 12 A 419 ALA PHE GLN ASP GLU ASN HIS LEU TYR LEU VAL MET ASP SEQRES 13 A 419 TYR TYR VAL GLY GLY ASP LEU LEU THR LEU LEU SER LYS SEQRES 14 A 419 PHE GLU ASP LYS LEU PRO GLU ASP MET ALA ARG PHE TYR SEQRES 15 A 419 ILE GLY GLU MET VAL LEU ALA ILE ASP SER ILE HIS GLN SEQRES 16 A 419 LEU HIS TYR VAL HIS ARG ASP ILE LYS PRO ASP ASN VAL SEQRES 17 A 419 LEU LEU ASP VAL ASN GLY HIS ILE ARG LEU ALA ASP PHE SEQRES 18 A 419 GLY SER CYS LEU LYS MET ASN ASP ASP GLY THR VAL GLN SEQRES 19 A 419 SER SER VAL ALA VAL GLY THR PRO ASP TYR ILE SER PRO SEQRES 20 A 419 GLU ILE LEU GLN ALA MET GLU ASP GLY MET GLY LYS TYR SEQRES 21 A 419 GLY PRO GLU CYS ASP TRP TRP SER LEU GLY VAL CYS MET SEQRES 22 A 419 TYR GLU MET LEU TYR GLY GLU THR PRO PHE TYR ALA GLU SEQRES 23 A 419 SER LEU VAL GLU THR TYR GLY LYS ILE MET ASN HIS GLU SEQRES 24 A 419 GLU ARG PHE GLN PHE PRO SER HIS VAL THR ASP VAL SER SEQRES 25 A 419 GLU GLU ALA LYS ASP LEU ILE GLN ARG LEU ILE CYS SER SEQRES 26 A 419 ARG GLU ARG ARG LEU GLY GLN ASN GLY ILE GLU ASP PHE SEQRES 27 A 419 LYS LYS HIS ALA PHE PHE GLU GLY LEU ASN TRP GLU ASN SEQRES 28 A 419 ILE ARG ASN LEU GLU ALA PRO TYR ILE PRO ASP VAL SER SEQRES 29 A 419 SER PRO SER ASP THR SER ASN PHE ASP VAL ASP ASP ASP SEQRES 30 A 419 VAL LEU ARG ASN THR GLU ILE LEU PRO PRO GLY SER HIS SEQRES 31 A 419 THR GLY PHE SER GLY LEU HIS LEU PRO PHE ILE GLY PHE SEQRES 32 A 419 THR PHE THR THR GLU SER CYS PHE SER ASP ARG GLY SER SEQRES 33 A 419 LEU LYS SER HET CL A 501 1 HET EDO A 502 4 HET EDO A 503 4 HET AQ5 A 504 26 HETNAM CL CHLORIDE ION HETNAM EDO 1,2-ETHANEDIOL HETNAM AQ5 (6~{S})-8-(3-PYRIMIDIN-4-YL-1~{H}-PYRROLO[2,3- HETNAM 2 AQ5 B]PYRIDIN-4-YL)-1,8-DIAZASPIRO[5.5]UNDECANE HETSYN EDO ETHYLENE GLYCOL FORMUL 2 CL CL 1- FORMUL 3 EDO 2(C2 H6 O2) FORMUL 5 AQ5 C20 H24 N6 FORMUL 6 HOH *156(H2 O) HELIX 1 AA1 SER A 2 ASN A 21 1 20 HELIX 2 AA2 SER A 26 SER A 42 1 17 HELIX 3 AA3 HIS A 43 ARG A 48 1 6 HELIX 4 AA4 ASP A 49 GLN A 70 1 22 HELIX 5 AA5 HIS A 72 GLU A 74 5 3 HELIX 6 AA6 LYS A 109 ARG A 115 1 7 HELIX 7 AA7 CYS A 120 GLY A 131 1 12 HELIX 8 AA8 ASP A 160 PHE A 168 1 9 HELIX 9 AA9 PRO A 173 LEU A 194 1 22 HELIX 10 AB1 LYS A 202 ASP A 204 5 3 HELIX 11 AB2 THR A 239 ILE A 243 5 5 HELIX 12 AB3 SER A 244 ASP A 253 1 10 HELIX 13 AB4 PRO A 260 GLY A 277 1 18 HELIX 14 AB5 SER A 285 ASN A 295 1 11 HELIX 15 AB6 ASN A 295 PHE A 300 1 6 HELIX 16 AB7 SER A 310 ARG A 319 1 10 HELIX 17 AB8 ILE A 333 LYS A 338 1 6 HELIX 18 AB9 HIS A 339 GLU A 343 5 5 HELIX 19 AC1 ASN A 349 LEU A 353 5 5 HELIX 20 AC2 HIS A 395 ILE A 399 5 5 SHEET 1 AA1 6 PHE A 76 ARG A 84 0 SHEET 2 AA1 6 GLU A 89 MET A 95 -1 O VAL A 92 N LYS A 80 SHEET 3 AA1 6 ILE A 101 ASN A 108 -1 O ILE A 106 N GLU A 89 SHEET 4 AA1 6 HIS A 148 MET A 153 -1 O MET A 153 N ALA A 103 SHEET 5 AA1 6 LEU A 139 GLN A 144 -1 N TYR A 141 O VAL A 152 SHEET 6 AA1 6 PHE A 403 THR A 404 -1 O PHE A 403 N ALA A 142 SHEET 1 AA2 2 TYR A 196 VAL A 197 0 SHEET 2 AA2 2 LEU A 223 LYS A 224 -1 O LEU A 223 N VAL A 197 SHEET 1 AA3 2 VAL A 206 LEU A 208 0 SHEET 2 AA3 2 ILE A 214 LEU A 216 -1 O ARG A 215 N LEU A 207 SITE 1 AC1 2 PHE A 391 LYS A 416 SITE 1 AC2 8 LYS A 105 LEU A 107 ALA A 119 CYS A 120 SITE 2 AC2 8 PHE A 121 GLU A 124 GLY A 220 HOH A 676 SITE 1 AC3 4 GLU A 28 THR A 404 SER A 407 HOH A 636 SITE 1 AC4 14 ILE A 82 ARG A 84 ALA A 103 LYS A 105 SITE 2 AC4 14 MET A 153 ASP A 154 TYR A 155 TYR A 156 SITE 3 AC4 14 ASP A 204 LEU A 207 PHE A 370 HOH A 627 SITE 4 AC4 14 HOH A 630 HOH A 635 CRYST1 115.190 44.056 91.845 90.00 107.60 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008681 0.000000 0.002753 0.00000 SCALE2 0.000000 0.022698 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011422 0.00000